Correlation Between Puma Biotechnology and Immatics Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Immatics Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Immatics Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and immatics biotechnologies GmbH, you can compare the effects of market volatilities on Puma Biotechnology and Immatics Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Immatics Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Immatics Biotechnologies.
Diversification Opportunities for Puma Biotechnology and Immatics Biotechnologies
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Puma and Immatics is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and immatics biotechnologies GmbH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immatics Biotechnologies and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Immatics Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immatics Biotechnologies has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Immatics Biotechnologies go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Immatics Biotechnologies
Given the investment horizon of 90 days Puma Biotechnology is expected to under-perform the Immatics Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Puma Biotechnology is 25.38 times less risky than Immatics Biotechnologies. The stock trades about -0.02 of its potential returns per unit of risk. The immatics biotechnologies GmbH is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 374.00 in immatics biotechnologies GmbH on December 4, 2024 and sell it today you would lose (372.00) from holding immatics biotechnologies GmbH or give up 99.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 84.49% |
| Values | Daily Returns |
Puma Biotechnology vs. immatics biotechnologies GmbH
Performance |
| Timeline |
| Puma Biotechnology |
| Immatics Biotechnologies |
Puma Biotechnology and Immatics Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Immatics Biotechnologies
The main advantage of trading using opposite Puma Biotechnology and Immatics Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Immatics Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics Biotechnologies will offset losses from the drop in Immatics Biotechnologies' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |